RARE - Ultragenyx Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.18B
Enterprise Value 32.77B
Trailing P/E N/A
Forward P/E 1-9.68
PEG Ratio (5 yr expected) 1-0.85
Price/Sales (ttm)121.75
Price/Book (mrq)4.50
Enterprise Value/Revenue 3106.08
Enterprise Value/EBITDA 6-7.90

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,402.96%

Management Effectiveness

Return on Assets (ttm)-35.09%
Return on Equity (ttm)-32.37%

Income Statement

Revenue (ttm)26.08M
Revenue Per Share (ttm)0.57
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-229.03M
EBITDA -350.08M
Net Income Avi to Common (ttm)-183.43M
Diluted EPS (ttm)-3.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)547.13M
Total Cash Per Share (mrq)10.9
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.16
Book Value Per Share (mrq)14.05

Cash Flow Statement

Operating Cash Flow (ttm)-309.37M
Levered Free Cash Flow (ttm)-175.65M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.02
52-Week Change 327.26%
S&P500 52-Week Change 37.95%
52 Week High 390.98
52 Week Low 341.67
50-Day Moving Average 378.17
200-Day Moving Average 372.89

Share Statistics

Avg Vol (3 month) 3490.89k
Avg Vol (10 day) 3681.68k
Shares Outstanding 550.18M
Float 46.87M
% Held by Insiders 16.46%
% Held by Institutions 1100.39%
Shares Short (Sep 28, 2018) 44.88M
Short Ratio (Sep 28, 2018) 410.33
Short % of Float (Sep 28, 2018) 413.70%
Short % of Shares Outstanding (Sep 28, 2018) 49.73%
Shares Short (prior month Aug 31, 2018) 44.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A